Impact of pharmacokinetics to reduce bleeding in a cohort of patients with severe hemophilia A in a personalized comprehensive management program
Introduction: In recent decades, hemophilia A treatment has been focused on body weight, without taking pharmacokinetic parameters into account. Previous research has shown that the individual pharmacokinetic response is more effective in predicting the required dose of clotting factor. We want to...
Enregistré dans:
Auteurs principaux: | Samuel sarmiento Doncel, Gina Alejandra Diaz Mosquera, Javier Mauricio Cortes, Nelson Ramirez, Francisco Javier Meza, Carol Agudelo Rico |
---|---|
Format: | article |
Langue: | EN |
Publié: |
PAGEPress Publications
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/a5ae7a1c44ac4daba6f5389cbcdbe17d |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
COMPARISON OF INDIVIDUAL PHARMACOKINETIC DOSING TOOLS IN PATIENTS WITH HEMOPHILIA A
par: Can Alp GENÇ, et autres
Publié: (2021) -
External qualification of the Web‐Accessible Population Pharmacokinetic Service–Hemophilia (WAPPS‐Hemo) models for octocog alfa using real patient data
par: Pierre Chelle, et autres
Publié: (2021) -
All bleeding matters … but the details may not
par: Sarah H. O’Brien
Publié: (2020) -
BLEEDING MANAGEMENT DURING DELIVERY AND POSTPARTUM PERIOD IN GLANZMANN THROMBASTHENIA: EXPERIENCES FROM TWO CASES
par: Özden ÖZLÜK, et autres
Publié: (2021) -
Derivation of a Pharmacokinetic Model to Include a Plasma-Derived, von Willebrand Factor-Containing Factor VIII (Koate-DVI) Concentrate and its Low-Dose Use
par: Dagmar M. Hajducek, et autres
Publié: (2021)